Association of apolipoprotein A5 gene polymorphisms with metabolic syndrome in the Korean population

Genetic Testing and Molecular Biomarkers

Volumn 20, Issue 3, 2016, Pages 130-136

  Kim, Young Ree ^a   Hong, Seung Ho ^b  

^a Jeju National University School of Medicine   (South Korea)

^b Jeju National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A5; TRIACYLGLYCEROL; APOA5 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; KOREAN (PEOPLE); MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CASE CONTROL STUDY; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; HYPERTRIGLYCERIDEMIA; LIPID METABOLISM; MIDDLE AGED; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH KOREA;

ADULT; APOLIPOPROTEIN A-V; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTRIGLYCERIDEMIA; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REPUBLIC OF KOREA; RISK FACTORS;

EID: 84960943592     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2015.0250     Document Type: Article

References (25)

1. Aouizerat BE, Kulkarni M, Heilbron D, et al. (2003) Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids. J Lipid Res 44:1167-1173.
2. Dallinga-Thie GM, van Tol A, Hattori H (2006) DALI study group. Plasma apolipoprotein A5 and triglycerides in type 2 diabetes. Diabetologia 49:1505-1511.
3. Dallongeville J, Cottel D, Montaye M, et al. (2006) Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men. Int J Cardiol 13: 152-156.
4. Dallongeville J, Cottel D, Wagner A, et al. (2008) The APOA5 Trp19 allele is associated with metabolic syndrome via its association with plasma triglycerides. BMC Med Genet 9:84.
5. DeFronzo RA, Ferrannini E (1991) Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194.
6. Ervin RB (2009) Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. Natl Health Stat Report 13:1-7.
7. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults. Adult Treatment Panel III). JAMA 285, 2486-2497.
8. Garelnabi M, Lor K, Jin J, et al. (2013) The paradox of ApoA5 modulation of triglycerides: evidence from clinical and basic research. Clin Biochem 12:12-19.
9. Grallert H, Sedlmeier EM, Huth C, et al. (2007) APOA5 variants and metabolic syndrome in Caucasians. J Lipid Res 48: 2614-2621.
10. Groenendijk M, Cantor RM, de Bruin TW, Dallinga-Thie GM (2001) The apoAI-CIII-AIV gene cluster. Atherosclerosis 157:1-11.
11. Groop L (2000) Genetics of the metabolic syndrome. Br J Nutr 83 Suppl 1:S39-S48.
12. Janghorbani M, Amini M (2012) Associations of hip circumference and height with incidence of type 2 diabetes: the Isfahan diabetes prevention study. Acta Diabetol Suppl 1: S107-S114.
13. Maasz A, Kisfali P, Horvatovich K, et al. (2007) Apolipoprotein A5 T-1131C variant confers risk for metabolic syndrome. Pathol Oncol Res 13:243-247.
14. Naukkarinen J, Ehnholm C, Peltonen L (2006) Genetics of familial combined hyperlipidemia. Curr Opin Lipidol 17:285-290.
15. Niculescu LS, Fruchart-Najib J, Fruchart JC, Sima A (2007) Apolipoprotein A-V gene polymorphisms in subjects with metabolic syndrome. Clin Chem Lab Med 45:1133-1139.
16. Park YW, Zhu S, Palaniappan L, et al. (2003) The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 163: 427-436.
17. Pennacchio LA, Olivier M, Hubacek JA, et al. (2001) An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294:169-173.
18. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning- A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
19. Shoulders CC, Jones EL, Naoumova RP (2004) Genetics of familial combined hyperlipidemia and risk of coronary heart disease. Hum Mol Genet 13 Spec No 1:R149-R160.
20. Talmud PJ, Hawe E, Martin S, et al. (2002) Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet 11:3039-3046.
21. Vaessen SF, Schaap FG, Kuivenhoven JA, et al. (2006) Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk Population Study. J Lipid Res 47:2064-2070.
22. Van der Vliet HN, Sammels MG, Leegwater AC, et al. (2001) Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration. J Biol Chem 276:44512-44520.
23. Van der Vliet HN, Schaap FG, Levels JH, et al. (2002) Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in mice. Biochem Biophys Res Commun 295:1156-1159.
24. Wannamethee SG, Shaper AG, Lennon L, Morris RW (2005) Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease stroke, and type 2 diabetes mellitus. Arch Intern Med 165:2644-2650.
25. Yamada Y, Kato K, Hibino T, et al. (2007) Prediction of genetic risk for metabolic syndrome. Atherosclerosis 191:298-304.